UroGen Pharma (URGN) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
| (NASDAQ: URGN) | Delayed: 34.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.40 | 52 Week High | $ | |||
| Open | $34.40 | 52 Week Low | $ | |||
| Day High | $34.40 | P/E | N/A | |||
| Day Low | $34.40 | EPS | $ | |||
| Volume | 16,810 | |||||
